Higher serum prolyl endopeptidase activity in patients with post- traumatic stress disorder

Journal of Affective Disorders

Volumn 53, Issue 1, 1999, Pages 27-34

  Maes, Michael ^a,b,c   Lin, Ai Hua ^a   Bonaccorso, Stefania ^a,d   Goossens, Filip ^e   Van Gastel, Ann ^a   Pioli, Rosaria ^c   Delmeire, Laure ^a   Scharpé, Simon ^e  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b VANDERBILT UNIVERSITY   (United States)

^c IRCSS   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Anxiety; Arginine vasopressin; Depression; Oxytocin; Peptidases; Peptides; Post traumatic stress disorder

Indexed keywords

ARGIPRESSIN; NEUROPEPTIDE; NEUROTENSIN; OXYTOCIN; PROLYL ENDOPEPTIDASE; PROTIRELIN; SUBSTANCE P;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EMOTION; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REINFORCEMENT; SCHIZOPHRENIA; SOCIAL INTERACTION;

ADULT; ARGININE VASOPRESSIN; DEPRESSIVE DISORDER, MAJOR; ENDOPEPTIDASES; FEMALE; FLUOROMETRY; HUMANS; MALE; MIDDLE AGED; NEUROTENSIN; OXYTOCIN; REINFORCEMENT (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE P; THYROTROPIN-RELEASING HORMONE;

EID: 0032941942     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(98)00086-X     Document Type: Article

References (53)

1. American Psychiatric Association, 1980. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. APA, Washington, DC.
2. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. APA Washington, DC.
3. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. APA, Washington, DC.
4. Bauer M., Priebe S., Kurten I., Graf K.-J., Baumgartner A. Psychological and endocrine abnormalities in refugees from East Germany: part I: prolonged stress, psychopathology, and hypothalamic-pituitary-thyroid axis activity. Psychiatr. Res. 51:1994;61-73.
5. Bluthe R.M., Schoenen J., Dantzer R. Androgen-dependent vasopressinergic neurons are involved in social recognition in rats. Brain Res. 159:1990;150-157.
6. Darnell A., Bremner J.D., Licinio J., Krystal J., Nemeroff C.B., Owens M., Erdos J., Charney D.S. CSF levels of corticotropin releasing factor in chronic post-traumatic stress disorder. Neurosci. Abstr. 20:1994;15A.
7. De Bellis M.D., Chrousos G.P., Dorn L.D., Burke L., Helmers K., Kling M.A., Trickett P.K., Putnam F.W. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J. Clin. Endocrinol. Metab. 78:1993;249-255.
8. Drago F., Pulvirenti L., Spadaro F., Pennisi G. Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats. Psychoneuroendocrinology. 15:1990;349-356.
9. Drago F., Coppi G., Antonuzzo P.A., Valerio C., Genazzani A.A., Grassi M., Raffaele R., Scapagnini U. Effects of RGH 2202 on cognitive and motor behavior of the rat. Neurobiol. Aging. 17:1996;67-71.
10. Engelmann M., Ludwig M., Landgraft R. Simultaneous monitoring of intracerebral release and behavior: endogenous vasopressin improves social recognition. J. Neuroendocrinol. 6:1994;391-395.
11. Goossens F., De Meester I., Vanhoof G., Scharpé S. A sensitive method for the assay of serum prolyl endopeptidase. Eur. J. Clin. Chem. Clin. Biochem. 30:1992;235-238.
12. Goossens F., De Meester I., Vanhoof G., Scharpe S. Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. Eur. J. Clin. Chem. Clin. Biochem. 34:1996;17-22.
13. Halbreich U., Olympia J., Carson S., Glogowski J., Yeh C.M., Axelrod S., Desu M.M. Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients. Psychoneuroendocrinology. 14:1989;365-370.
14. Hopsu-Havu V.K., Glenner G.G. A new dipeptide naphthylamidase hydrolyzing glycyl-propyl-β-naphthylamide. Histochemisty. 7:1966;197-201.
15. Insel T.R. Oxytocin: a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic and comparative studies. Psychoneuroendocrinology. 17:1992;3-35.
16. Janca A., Ustün T.B., Sartorius N. New versions of World Health Organization instruments for the assessment of mental disorders. Acta Psychiatr. Scand. 90:1994;73-83.
17. Kato T., Nakano T., Kojima K., Nagatsu T., Sakakibara S. Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzyme. J. Neurochem. 35:1980;527-535.
18. Kato T., Okada M., Nagatsu T. Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues. Mol. Cell. Biochem. 32:1980;117-121.
19. Kosten T.R., Mason J.W., Giller E.L., Ostroff R.B., Harkness L. Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. Psychoneuroendocrinology. 12:1987;13-20.
20. Krappmann P., Hasenohrl R.U., Frisch C., Huston J.P. Self-administration of neurokinin substance P into the ventromedial caudate-putamen in rats. Neuroscience. 62:1994;1093-1101.
21. Lawrence A.C., Clark I.J., Campbell D.J. Increased angiotensin-(1-7) in hypophysial-portal plasma of conscious sheep. Neuroendocrinology. 55:1992;105-114.
22. Lemieux A.M., Coe C.L. Abuse-related post-traumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom. Med. 57:1995;105-115.
23. McCarthy M.M. Estrogen modulation of oxytocin and its relation to behavior. Adv. Exp. Med. Biol. 395:1995;235-245.
24. Maes, M., 1997. The immune pathophysiology of major depression. In: Honig, A., van Praag, H. (Eds.), Depression: Neurobiological, Psychopathological and Therapeutic Advances. Wiley, Chichester, pp. 197-215.
25. Maes M., Minner B., Suy E., Vandervorst C., Raus J. Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal axis in melancholia. J. Neural. Transm. 85:1991;195-210.
26. Maes M., Goossens F., Scharpe S., Meltzer H.Y., D'Hondt P., Cosyns P. Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol. Psychiatry. 35:1994;545-552.
27. Maes M., Scharpe S., Meltzer H.Y., Calabrese J. Plasma prolyl endopeptidase enzyme activity in major depression, schizophrenia and mania: effects of antidepressive drugs, neuroleptics and valproate. Psychiatry Res. 58:1995;217-225.
28. Maes, M., Delmeire, L., Mylle, J., Schotte, C., Janca, A., 1998a. Epidemiologic and phenomenological aspects of post-traumatic stress disorder: DSM-III-R diagnosis and diagnostic criteria not validated. Psychiatry Res., accepted.
29. Maes, M., Delmeire, L., Mylle, J., Schotte, C., Janca, A., 1998b. The two-factorial symptom structure of post-traumatic stress disorder: depression-avoidance and arousal-anxiety. Psychiatry Res., in press.
30. Maes, M., Goossens, F., Lin, A., De Meester, I., Van Gastel, A., Scharpe, S., 1998c. Effects of psychological stress on serum prolyl endopeptidase (PEP) and dipeptidyl peptidase activity: higher serum PEP is related to stress-induced anxiety. Psychoneuroendocrinology, accepted.
31. Maes, M., Lin, A., Bonnaccorso, S., van hunsel, F., Van Gastel, A., Delmeire, L., Biondi, M., Bosmans, E., Kenis, G., Scharpe, S., 1998d. Increased baseline hypothalamic-pituitary-adrenal axis activity in patients with post-traumatic stress disorder and major depression, but not in patients with fibromyalgia. Acta Psychiatr. Scand., in press.
32. Maes, M., Lin, A., Delmeire, L., Van gastel, A., Kenis, G., Bosmans, E., De Jongh, R., 1998e. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in post-traumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry, in press.
33. Metzger D., Alescio Lautier B., Soumireu Mourat B. Involvement of alpha and beta-noradrenergic receptors in the effects of hippocampal vasopressinergic treatment on retrieval and relearning. Behav. Neural. Biol. 62:1994;90-99.
34. Peters L., Andrews G., Cottler L.B., Chatter S., Janca A., Smeets R.M.W. The Composite International Diagnostic Interview Post-Traumatic Stress Disorder Module: preliminary data. Int. J. Meth. Psychiatr. Res. 6:1996;167-174.
35. Pitman R., Orr S. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related post-traumatic stress disorder. Biol. Psychiatry. 27:1990;245-247.
36. Popik P., Vetulani J. Similar action of imipramine and arginine vasopressin in the social interaction test. Pol. J. Pharmacol. 45:1993;323-325.
37. Rinaman, L., Sherman, T.G., Stricker, E.M., 1995. Vasopressin and oxytocin in the central nervous system. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology, the Fourth Generation of Progress. Raven Press, New York, pp. 933-944.
38. Rompre P.P. Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward. Peptides. 16:1995;1417-1420.
39. Rompre P.P., Bauco P. Gratton-A facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1-13). Eur. J. Pharmacol. 211:1992;295-303.
40. Schiavone M.T., Santos R.A.S., Brosnihan K.B., Khosla M.C. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc. Natl. Acad. Sci. USA. 85:1988;4095-4098.
41. Smith M.A., Davidson J., Ritchie J.C., Kudler H., Lipper S., Chappell P., Nemeroff C.B. The corticotropin releasing hormone test in patients with post-traumatic stress disorder. Biol. Psychiatry. 26:1989;349-355.
42. Spitzer, R.L., Williams, J.B.W., Gibbon, M.S.W., First, M.B., 1990. Structured Clinical Interview according to DSM-III-R. American Psychiatric Press, Washington, DC.
43. Spivak B., Shohat B., Mester R., Avraham S., Gil-Ad I., Bleich A., Valevski A., Weizman A. Elevated levels of serum interleukin-1 in combat-related post-traumatic stress disorder. Biol. Psychiatry. 42:1997;345-348.
44. Stoehr J.D., Cramer C.P., North W.G. Oxytocin and vasopressin hexapeptide fragments have opposing influences on conditioned freezing behavior. Psychoneuroendocrinology. 17:1992;267-271.
45. Uvnas Moberg K., Ahlenius S., Hillegaart V., Alster P. High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol. Biochem. Behav. 49:1994;101-106.
46. Vanhoof G., De Meester I., van Sande M., Scharpe S., Yaron A. Distribution of proline-specific aminopeptidases in human tissues and body fluids. Eur. J. Clin. Chem. Clin. Biochem. 30:1992;333-338.
47. van London L., Goekoop J.G., van Kempen G.M.J., Frankhuyzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., De Wied D. Plasma levels of arginin vasopressin elevated in patients with major depression. Neuropsychopharmacology. 17:1997;284-292.
48. Wang S., Mason J., Southwick S., Johnson D., Lubin H., Charney D. Relationships between thyroid hormones and symptoms in combat-related post-traumatic stress disorder. Psychosom. Med. 57:1995;398-402.
49. Welches W.R., Brosnihan K.B., Ferrario C.M. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci. 52:1993;1461-1480.
50. Wilk S. Prolyl endopeptidase. Life Sci. 33:1983;2149-2157.
51. Witt D.M., Winslow J.T., Insel T.R. Enhanced social interactions in rats following chronic, centrally infused oxytocin. Pharmacol. Biochem. Behav. 43:1992;855-861.
52. Wolfe, J., Keane, T.M., 1990. Diagnostic validity of post-traumatic stress disorder. In: Wolf, M.E., Mosnaim, A.D. (Eds.), Post-Traumatic Stress Disorder: Etiology, Phenomenology and Treatments, APA, Washington, DC, pp. 49-63.
53. Yehuda R., Levengood R.A., Schmeidler J., Wilson S., Guo L.S., Gerber D. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology. 21:1996;1-16.